CytomX Therapeutics, Inc. Common Stock (CTMX)

Typically moves ±17.28% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

CytomX Therapeutics, Inc. Common Stock (CTMX) has reported earnings 20 times since Aug 05, 2021. The stock moves an average of ±17.28% the day after reporting, closing higher 60.0% of the time. Its largest post-earnings gain was +125.78% (May 12, 2025) and its largest decline was -51.43% (May 08, 2024). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings reactions

How CTMX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±17.28%

Positive %

60.0%

Negative %

40.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☽ POST	-0.25%	open_in_new
Mar 16, 2026	☀ PRE	+44.02%	open_in_new
Nov 06, 2025	☽ POST	-13.69%	open_in_new
Aug 07, 2025	☽ POST	+12.92%	open_in_new
May 12, 2025	☀ PRE	+125.78%	open_in_new
Mar 06, 2025	☽ POST	+7.39%	open_in_new
Nov 07, 2024	☽ POST	+10%	open_in_new
Aug 08, 2024	☽ POST	+0.83%	open_in_new
May 08, 2024	☽ POST	-51.43%	open_in_new
Mar 11, 2024	☽ POST	-14%	open_in_new
Nov 07, 2023	☽ POST	-2.29%	open_in_new
Aug 08, 2023	☽ POST	-3.24%	open_in_new
May 09, 2023	☽ POST	+6.43%	open_in_new
Mar 27, 2023	☽ POST	-15.64%	open_in_new
Nov 08, 2022	☽ POST	+0%	open_in_new
Aug 04, 2022	☽ POST	+2.46%	open_in_new
May 05, 2022	☽ POST	+1.25%	open_in_new
Mar 01, 2022	☽ POST	+14.39%	open_in_new
Nov 04, 2021	☽ POST	+10.42%	open_in_new
Aug 05, 2021	☽ POST	-9.11%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±17.28%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 16 →

Funds holding

$120456532

Total value held

Buying

13 added · 3 reduced

Bank Of America Corp /De/

$47953089 +1064.30%

State Street Corp

$26618018 +10.16%

Blackrock, Inc.

$24572917 +42.48%

Goldman Sachs Group Inc

$6861244 -40.68%

Barclays Plc

$3959336 NEW BUY

SEC Filing Types

description 4

8 chevron_right

description SCHEDULE 13G/A

5 chevron_right

description 8-K

2 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
4	20260617	open_in_new SEC.gov
8-K	20260603	open_in_new SEC.gov

Frequently asked about CTMX earnings

When does CytomX Therapeutics, Inc. Common Stock report earnings next? expand_more

CytomX Therapeutics, Inc. Common Stock (CTMX)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CTMX stock move after earnings? expand_more

Over 20 reports, CTMX has moved an average of ±17.28% the session after earnings, closing higher 60.0% of the time.

What was CTMX's biggest post-earnings move? expand_more

CTMX's largest post-earnings gain on record was +125.78% on May 12, 2025, and its largest decline was -51.43% on May 08, 2024.

Where can I find CytomX Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of CytomX Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.